跳至主要内容
临床试验/NL-OMON51962
NL-OMON51962招募中2 期

Phase II non-randomized study on proton radiotherapy of thymic malignancies - PROTHYM

Swedish Lung Cancer Study Group0 个研究点目标入组 10 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • - Histological or cytological diagnosis of thymoma or thymic carcinoma
  • - With radical surgery stage III, IV and selected stage II with type B2, B3 or
  • thymic carcinoma according to local routine
  • - With non-radical surgery (R1 or R2), stage I - IVa, any histology
  • - Medically inoperable or patient refusing surgery, stage I - IVa, any histology
  • - PS WHO 0-2
  • - FEV1 >/1l or >/40% of predicted and CO diffusion capacity >40% of predicted
  • (post-operative measures)
  • - Age >/18 years, no upper age limit
  • - Written informed consent

排除标准

  • - Masoaka-Koga stage IVb (distant metastases)
  • - Pregnancy
  • - Serious concomittant systemic disorder incompatible with the study
  • - Tumour motion >0,5cm on two repeated 4DCT

研究者

发起方
Swedish Lung Cancer Study Group

相似试验